Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates

International Journal of Antimicrobial Agents

Volumn 47, Issue 1, 2016, Pages 62-68

  Alonso, Noemí ^a,b,c   Miró, Elisenda ^a,c   Pascual, Vanesa ^d   Rivera, Alba ^a   Simó, Maria ^e   Garcia, Maria Consol ^f   Xercavins, Mariona ^e   Morera, Maria Antonia ^e   Espejo, Elena ^f   Gurguí, Mercè ^a,b,c   Pérez, Josefa ^e   Rodríguez Carballeira, Mònica ^d   Garau, Javier ^d   Calbo, Esther ^d,g   Navarro, Ferran ^a,b,c   Mirelis, Beatriz ^a,b,c   Coll, Pere ^a,b,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e Catlab   (Spain)

^f Brain   (Spain)

^g UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

AmpC promoter; Antimicrobial resistance; Cephalosporins; pMLST; PMQR

Indexed keywords

BETA LACTAMASE AMPC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; AMPC BETA-LACTAMASES; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLAAMPC GENE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; PLASMID; POPULATION STRUCTURE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QEPA GENE; QNRA GENE; QNRB GENE; QNRS GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPAIN; UPREGULATION; BACTERIAL CHROMOSOME; CHEMISTRY; CLASSIFICATION; DNA FINGERPRINTING; DNA SEQUENCE; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENE EXPRESSION; GENETIC VARIATION; GENETICS; HORIZONTAL GENE TRANSFER; HUMAN; METABOLISM; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION;

BACTERIAL PROTEINS; BETA-LACTAMASES; CHROMOSOMES, BACTERIAL; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; GENETIC VARIATION; HUMANS; MULTILOCUS SEQUENCE TYPING; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; QUINOLONES; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 84953835248     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.10.007     Document Type: Article

References (39)

1. G.A. Jacoby AmpC β-lactamases Clin Microbiol Rev 22 2009 161 182
2. D.M. Tracz, D.A. Boyd, R. Hizon, E. Bryce, A. McGeer, M. Ofner-Agostini, and et al. Canadian Nosocomial Infection Surveillance Program, ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates FEMS Microbiol Lett 270 2007 265 271
3. B. Haldorsen, B. Aasnaes, K.H. Dahl, A.M. Hanssen, G.S. Simonsen, T.R. Walsh, and et al. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC J Antimicrob Chemother 62 2008 694 702
4. H. Guillom, D. Tande, and H. Mammeri Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum β-lactamase AmpC Antimicrob Agents Chemother 55 2011 4443 4446
5. H. Mammeri, H. Guillon, F. Eb, and P. Nordmann Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases Antimicrob Agents Chemother 54 2010 4556 4560
6. H. Radhouani, N. Silva, P. Poeta, C. Torres, S. Correia, and G. Igrejas Potential impact of antimicrobial resistance in wildlife, environment and human health Front Microbiol 5 2014 23
7. G.M. Voets, A.C. Fluit, J. Scharringa, C. Schapendonk, T. van den Munckhof, M.A. Leverstein-van Hall, and et al. Identical plasmid AmpC β-lactamase genes and plasmid types in E. coli isolates from patients and poultry meat in The Netherlands Int J Food Microbiol 167 2013 359 362
8. European Committee on Antimicrobial Susceptibility Testing. EUCAST guideline for the detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance v 1.0 (2013-12-11). http://www.eucast.org/resistance-mechanisms/ [accessed 20.10.15].
9. L. Siu, P.L. Lu, F. Lin, and S.C. Chang High-level expression of AmpC β-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment Antimicrob Agents Chemother 47 2003 2138 2144
10. Y.S. Park, S. Yoo, M.R. Seo, J.Y. Kim, Y.K. Cho, and H. Pai Risk factors and clinical features of infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae Int J Antimicrob Agents 34 2009 38 43
11. A.J. Denisuik, P.R. Lagacé-Wiens, J.D. Pitout, M.R. Mulvey, P.J. Simner, F. Tailor, and et al. Molecular epidemiology of extended-spectrum β-lactamase- AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11 J Antimicrob Chemother 68 Suppl1 2013 i57 i65
12. S. Shayan, M. Bokaeian, and S. Shahraki Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from Southeastern Iran Microb Drug Resist 20 2014 104 107
13. M.J. Park, T.K. Kim, W. Song, J.S. Kim, H.S. Kim, and J. Lee An increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010 Ann Lab Med 33 2013 353 355
14. E. Miró, J. Agüero, M.N. Larrosa, A. Fernández, M.C. Conejo, G. Bou, and et al. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain Eur J Clin Microbiol Infect Dis 32 2013 253 259
15. F. Galán-Sánchez, P. Aznar-Marín, and P. Marín-Casanova Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates APMIS 122 2013 796 799
16. M. Gude, C. Seral, Y. Sáenz, R. Cebollada, M. González-Domínguez, C. Torres, and et al. Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing Enterobacteriaceae Int J Med Microbiol 303 2013 553 557
17. M. Sabaté, E. Miró, F. Navarro, C. Vergés, R. Aliaga, B. Mirelis, and et al. β-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996 in Barcelona (Spain) J Antimicrob Chemother 49 2002 989 997
18. J. Oteo, E. Cercenado, O. Cuevas, V. Bautista, A. Delgado-Iribarren, B. Orden, and et al. AmpC β-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393 and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131 Diagn Microbiol Infect Dis 67 2010 270 276
19. A. Ortega, J. Oteo, M. Aranzamendi-Zaldumbide, R.M. Bartolomé, G. Bou, E. Cercenado, and et al. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli Antimicrob Agents Chemother 56 2012 3576 3581
20. V. Pascual, G. Ortiz, M. Simó, N. Alonso, M.C. Garcia, M. Xercavins, and et al. Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli J Antimicrob Chemother 70 2015 899 904
21. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20 2010 CLSI Wayne, PA
22. F.J. Pérez-Pérez, and N.D. Hanson Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR J Antimicrob Chemother 40 2002 2153 2162
23. R.L. Jorgensen, J.B. Nielsen, A. Friis-Moller, H. Fjedsoe-Nielsen, and K. Schonning Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype J Antimicrob Chemother 65 2010 460 464
24. O. Clermont, J. Christenson, E. Denamur, and D. Gordon The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups Environ Microbiol Rep 5 2013 58 65
25. A. Robicsek, J. Strahilevitz, G.A. Jacoby, M. Macielaq, D. Abbanat, C.H. Park, and et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Nat Med 12 2006 83 88
26. B. Shaheen, R. Nayak, S. Foley, and D.M. Boothe Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA J Antimicrob Chemother 68 2013 1019 1024
27. A. Carattoli, A. Bertini, L. Villa, V. Falbo, K.L. Hopkins, and E.J. Threlfall Identification of plasmids by PCR-based replicon typing J Microbiol Methods 63 2005 219 228
28. C. Mata, E. Miró, A. Alvarado, M.P. Garcillán-Barcia, M. Toleman, T.R. Walsh, and et al. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007 J Antimicrob Chemother 67 2012 115 122
29. A. García-Fernández, G. Chiaretto, A. Bertini, L. Villa, S. Fortini, A. Ricci, and et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin J Antimicrob Chemother 61 2008 1229 1233
30. L. Villa, A. García-Fernández, D. Fortini, and A. Carattoli Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants J Antimicrob Chemother 65 2010 2518 2529
31. P. Bogaerts, H. Rodríguez-Villalobos, C. Bauraing, A. Deplano, C. Laurent, C. Berhin, and et al. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals Pathol Biol 58 2010 78 83
32. S. Peter-Getzlaff, S. Polsfuss, M. Poledica, M. Hombach, J. Giger, E.C. Bötger, and et al. Detection of AmpC β-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis J Clin Microbiol 49 2011 2924 2932
33. A.H. van Hoek, L. Schouls, M.G. van Santen, A. Florijn, S.C. de Greeff, and E. van Duijkeren Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community PLOS ONE 10 2015 e0129085
34. S. Paltansing, M.E. Kraakman, J.M. Ras, E. Wessels, and A.T. Bernards Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE J Antimicrob Chemother 68 2013 40 45
35. H.E. Sidjabat, D.L. Paterson, Z.A. Qureshi, J.M. Adams-Haduch, A. O'Keefe, A. Pascual, and et al. Clinical features and molecular epidemiology of CMY-type β-lactamase-producing Escherichia coli Clin Infect Dis 48 2009 739 744
36. F. Hansen, S. Olsen, O. Heltberg, U.S. Justesen, D. Fuglsang-Damgaard, J.D. Knudsen, and et al. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark Microb Drug Resist 20 2014 316 324
37. DHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospital Clin Microbiol Infect 17 2011 1514 1517
38. CMY-2 amongst Escherichia coli Int J Antimicrob Agents 44 2014 203 208
39. CMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA J Antimicrob Chemother 69 2014 1492 1496